MEDICINES
TO KEEP YOU
BIOLOGICALLY YOUNG

TARGETING THE PATHOLOGICAL CELLS THAT DRIVE AGING

MORE LIFE TO YEARS

Medicines that work
if, where & when
needed

Powered by our drug discovery computational platform ALEMBIC™ and enabled by our proprietary chemistry engineering, Rubedo makes novel drugs designed to be selective and safe. 

Rubedo’s lead small molecules are engineered to be activated in pathological cells that drive age-related diseases but inactive in the healthy cells. 

NEWSFEED

Rubedo wins the Biotechnology Award 2022

Rubedo collaborates with Cedars-Sinai on senolytic IPF program

Venture Capitalists Back Biotech Push to Combat Aging

Rubedo featured among top senolytic companies in Nature Biotechnology

PIPELINE

The Possibilities Are Endless

INVESTORS

logo-khosla-venures copy@2x

CAREERS

We welcome all applicants regardless of gender, sexual orientation, ethnicity, race, education, age, or other personal characteristics

Rubedo Life Sciences , Inc

Silicon Valley, CA, USA

Copyright 2020 by Rubedo Life Sciences, inc